

Record annuity demand creates opportunities for Prudential, Principal Financial and MetLife as retirement needs and pension solutions grow.

MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE: MET), today announced the close of Galaxy 38 CLO, Ltd.

WHIPPANY, N.J.--(BUSINESS WIRE)--MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE: MET), today announced the close of Galaxy 38 CLO, Ltd. (Galaxy 38), a $450 million target par new issue collateralized loan obligation (CLO). PineBridge Investments, which is part of MIM, serves as collateral manager for the transaction. BofA Securities, Inc. acted as arranger. Galaxy 38 marks the 45th CLO issuance by the Leveraged Finance team, building on t.

RYBREVANT FASPRO⢠(amivantamab and hyaluronidase-lpuj) plus LAZCLUZE (lazertinib) with prophylactic strategies shows low rates of treatment-related events a

MetLife (NYSE: MET - Get Free Report) and Global Indemnity Group (NASDAQ: GBLI - Get Free Report) are both finance companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, earnings, analyst recommendations, profitability, institutional ownership, valuation and risk. Valuation and Earnings This table compares MetLife and

NewEdge Advisors LLC boosted its stake in shares of MetLife, Inc. (NYSE: MET) by 20.1% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 74,002 shares of the financial services provider's stock after purchasing an additional 12,378 shares during

Johnson and Johnson's RYBREVANTÂ (amivantamab-vmjw) plus chemotherapy delivers longest reported median overall survival in EGFR exon 20 insertion mutation-positi

Insurance companies collect your premiums today and settle your claims years from now, and that gap is quietly becoming a profit engine as rates stay elevated.
SEC filings for MET aren't indexed yet — common for recently launched funds. Browse the issuer's filings on SEC EDGAR directly.